<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/64F5B912-92CD-489B-A071-6CA22EFAAAA9"><gtr:id>64F5B912-92CD-489B-A071-6CA22EFAAAA9</gtr:id><gtr:name>Weizmann Institute of Science</gtr:name><gtr:address><gtr:line1>PO Box 26</gtr:line1><gtr:line2>Rehovot 76100</gtr:line2><gtr:line4>Rehovot</gtr:line4><gtr:postCode>76100</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/33952E5D-60ED-4D33-8638-669D9CFF6674"><gtr:id>33952E5D-60ED-4D33-8638-669D9CFF6674</gtr:id><gtr:name>Swiss Federal Institute of Technology (ETH), Zurich</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/FD96510E-B320-46B0-BCCC-E801CBFAA6D2"><gtr:id>FD96510E-B320-46B0-BCCC-E801CBFAA6D2</gtr:id><gtr:name>University of Massachusetts Med School</gtr:name><gtr:address><gtr:line4>Worcester</gtr:line4><gtr:line5>Massachusetts</gtr:line5><gtr:postCode>M01655</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F25BC0C5-5284-441F-B79F-A61707946CA0"><gtr:id>F25BC0C5-5284-441F-B79F-A61707946CA0</gtr:id><gtr:name>University of California Los Angeles</gtr:name><gtr:address><gtr:line1>405 Hillgard Avenue</gtr:line1><gtr:line2>Box 951361</gtr:line2><gtr:postCode>90095</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/EE34007E-A8DD-4B0A-81BF-56D38AB47C32"><gtr:id>EE34007E-A8DD-4B0A-81BF-56D38AB47C32</gtr:id><gtr:name>Institute of Cancer Research</gtr:name><gtr:department>Division of Breast Cancer Research</gtr:department><gtr:address><gtr:line1>123 Old Brompton Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW7 3RP</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/EE34007E-A8DD-4B0A-81BF-56D38AB47C32"><gtr:id>EE34007E-A8DD-4B0A-81BF-56D38AB47C32</gtr:id><gtr:name>Institute of Cancer Research</gtr:name><gtr:address><gtr:line1>123 Old Brompton Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>SW7 3RP</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/64F5B912-92CD-489B-A071-6CA22EFAAAA9"><gtr:id>64F5B912-92CD-489B-A071-6CA22EFAAAA9</gtr:id><gtr:name>Weizmann Institute of Science</gtr:name><gtr:address><gtr:line1>PO Box 26</gtr:line1><gtr:line2>Rehovot 76100</gtr:line2><gtr:line4>Rehovot</gtr:line4><gtr:postCode>76100</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Israel</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/33952E5D-60ED-4D33-8638-669D9CFF6674"><gtr:id>33952E5D-60ED-4D33-8638-669D9CFF6674</gtr:id><gtr:name>Swiss Federal Institute of Technology (ETH), Zurich</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/FD96510E-B320-46B0-BCCC-E801CBFAA6D2"><gtr:id>FD96510E-B320-46B0-BCCC-E801CBFAA6D2</gtr:id><gtr:name>University of Massachusetts Med School</gtr:name><gtr:address><gtr:line4>Worcester</gtr:line4><gtr:line5>Massachusetts</gtr:line5><gtr:postCode>M01655</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F25BC0C5-5284-441F-B79F-A61707946CA0"><gtr:id>F25BC0C5-5284-441F-B79F-A61707946CA0</gtr:id><gtr:name>University of California Los Angeles</gtr:name><gtr:address><gtr:line1>405 Hillgard Avenue</gtr:line1><gtr:line2>Box 951361</gtr:line2><gtr:postCode>90095</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/5A8676AF-C11B-4A4D-B5F2-0080C40C4E02"><gtr:id>5A8676AF-C11B-4A4D-B5F2-0080C40C4E02</gtr:id><gtr:firstName>Pascal</gtr:firstName><gtr:surname>Meier</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/D1A29835-1433-4574-88A6-308E605827CD"><gtr:id>D1A29835-1433-4574-88A6-308E605827CD</gtr:id><gtr:firstName>Mariam</gtr:firstName><gtr:surname>Orme</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G1000089"><gtr:id>87D4F102-7477-4181-A35F-E93346DAE53B</gtr:id><gtr:title>Regulation of Caspase Activation</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G1000089</gtr:grantReference><gtr:abstractText>In animals, the behaviour of the cells that make up the body must be tightly controlled in time and space. Part of this control stems from a built-in ?auto-destruct mechanism?, called apoptosis. This mechanism is carried within each cell, and through it the cell is instructed to die if it becomes potentially harmful or is no longer required. In order for an animal to remain healthy, apoptosis must be tightly regulated. Indeed, numerous human diseases result from the loss of this regulation. In cancer, for example, mutated cells escape apoptosis, allowing them grow and divide inappropriately; the consequence is a tumour. On the other hand, when brain cells undergo apoptosis inappropriately, neurodegenerative disease results. Thus maintenance of the correct balance of apoptosis is vital, but the molecular mechanisms underlying this process are not well understood. Our aim, therefore, is to unravel the molecular machinery that controls apoptosis. Our work concentrates on a group of highly specialised enzymes called caspases, which function as the engines of the apoptotic programme. By elucidating how caspases become activated under normal conditions, we will gain a better understanding of how apoptosis becomes deregulated in human diseases.</gtr:abstractText><gtr:technicalSummary>Abstract:
It is now clear that almost every aspect of human life is intimately enmeshed with the proper regulation of cell death, and failure in this regulation contributes to or forms the basis of most human disease pathogenesis such as cancer, autoimmune disease, neurodegenerative disorders and persistent viral infection. However, despite the identification of key players of the cell death machinery, surprisingly little is known about how caspases are activated and how this potentially catastrophic event is regulated. Although it is clear that initiator caspases are activated within macro-molecular complexes, such as the apoptosome, it remains elusive how initiator caspases are actually recruited into these caspase-activating structures. 

Our preliminary data indicate that the atypical myosin Myosin-7A directly binds to initiator caspases and regulates caspase activation and cell death. The observation that loss of Myosin-7A suppresses stress-induced as well as developmentally-regulated cell death in Drosophila, has provided an unexpected clue to the mechanism of caspase activation. Here, we propose to elucidate how Myosin-7A contributes to activation of caspases and cell death. Since myosins are mechanochemical proteins that primarily serve in intracellular movements, we will investigate whether Myosin-7A influences the subcellular localisation of initiator caspases, and whether this contributes to the recruitment of initiator caspases to apoptosomes following cell death stimuli. We will map the domains required and investigate the evolutionary conservation of Myosin-7A-mediated activation of caspases. Initially we will use Drosophila as an entry point due to its reduced complexity and rapid in vivo validation. Because the core elements of the apoptotic machinery are highly conserved, our findings from Drosophila will help us to investigate the role of human Myosin-7A in regulating caspase activation. 

Unravelling how Myosin-7A contributes to caspase regulation is critically important, as failure to induce cell death contributes to a variety of human diseases.</gtr:technicalSummary><gtr:fund><gtr:end>2013-09-30</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2010-10-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>348346</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>Identification of specific Ubiquitin chains on components of the TNF receptor signalling complex</gtr:description><gtr:id>D820DC0C-B2D9-41CD-AE07-45FA3ADD51AA</gtr:id><gtr:impact>the study that reports the findings from this collaboration is currently under review at Molecular Cell.</gtr:impact><gtr:partnerContribution>The collaborator has provided us with recombinant enzymes that allowed us to investigate the Ubiquitin linkage types that are conjugated to components of the TNF receptor signalling complex.</gtr:partnerContribution><gtr:piContribution>we have provide novel findings to address the question what types of signalling chains are conjugated to specific components of the TNF receptor signalling complex.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of California, Los Angeles (UCLA)</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Jules Stein Eye Institute UCLA</gtr:department><gtr:description>MYOSIN-7A mediated regulation of cell survival</gtr:description><gtr:id>D69AD6D9-778E-412F-9AA3-08171574DDC2</gtr:id><gtr:impact>Identified the regulatory mechanism of MYOSIN-7A-mediated regulation of cell survival</gtr:impact><gtr:partnerContribution>shared MYOSIN-7A reagents</gtr:partnerContribution><gtr:piContribution>using MYOSIN-7A reagents we made new discoveries implicating MYOsin-7A in the regulation of cell death, migration and cell invasion</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Weizmann Institute of Science</gtr:collaboratingOrganisation><gtr:country>Israel, State of</gtr:country><gtr:department>Laboratory of Body and Mind Immunology Weizmann</gtr:department><gtr:description>non-apoptotic signalling roles of apoptosome components in sperm maturation and differentiation</gtr:description><gtr:id>D5696192-30E2-40E1-8E5D-2D6AB84243EE</gtr:id><gtr:impact>The ms is currently finalised to be submitted to Nature Cell Biology at the end of November.</gtr:impact><gtr:partnerContribution>Eli Arama and co-workers evaluated the importance of Crinkled in activation of the initiator caspase Dronc and subsequent regulation of sperm cell individualisation.</gtr:partnerContribution><gtr:piContribution>We identified the protein Crinkled as a key regulator of the Drosophila apoptosome in apoptotic and non-apoptotic signalling. We then collaborated with Eli Arama at the Weizmann Institute to evaluate the role of Crinkled in Sperm cell individualisation and maturation.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Swiss Federal Institute of Technology Zurich (Eidgen?ssische Technische Hochschule Z?rich ETH)</gtr:collaboratingOrganisation><gtr:country>Switzerland, Swiss Confederation</gtr:country><gtr:department>Institute of Molecular Systems Biology</gtr:department><gtr:description>Mass spectrometric identification of binding partners of the apoptosome</gtr:description><gtr:id>02B7E57D-30D8-416C-8A54-E048B92700C3</gtr:id><gtr:impact>Successfully identified the interactome of the apoptosome in Drosophila.</gtr:impact><gtr:partnerContribution>This collaboration identified new regulators of the apoptosome using large scale affinity purification followed by mass spectrometric characterisation of binding partners.</gtr:partnerContribution><gtr:piContribution>This collaboration identified new regulators of the apoptosome using large scale affinity purification followed by mass spectrometric characterisation of binding partners.</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Massachusetts Medical School</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:department>Department of Cancer Biology</gtr:department><gtr:description>Developmental control of cell death</gtr:description><gtr:id>45EB904D-7167-449F-822A-0F0A58BFA745</gtr:id><gtr:impact>Characterise the developmental role of the apoptosome, and its regulation</gtr:impact><gtr:partnerContribution>Established the developmental impact mediated by components of the apoptosome</gtr:partnerContribution><gtr:piContribution>Established the developmental impact mediated by components of the apoptosome</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Awareness event at the House of Lords</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>7EC9F911-F7C4-47F8-BF2C-7A6DABE41EB3</gtr:id><gtr:impact>Talk and discussion groups brought together clinicians, fundamental biologists, researchers from pharmaceutical companies, policymakers and end users to discuss how breast cancer research, and novel treatment regiments, could be improved via a change in clinical practice for patient benefit.

Apart from a positive feedback, there were no recordable impacts.</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Fundraising event at the Breast Cancer Now Research Centre</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>6068421E-0D05-4E23-A161-256A835EC4B2</gtr:id><gtr:impact>A series of fund raising events took place throughout these years, each event saw 20 -30 people taking part. Ongoing research was communicated orally, which led to lively exchanges of questions and answers

Fundraisers liked the event, which prompted many repeat venues in which the current project was explained in great details</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>We have improve the UbiCrest technique that allows the characterisation of Ubiquitin-dependent signalling events</gtr:description><gtr:id>1D6878D3-7230-4F81-B8C8-CC8630A0D7FE</gtr:id><gtr:impact>This will allow to dissect the signalling events that control inflammation and cancer development</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Ubiquitin restriction analysis</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We generated several transgenic flies for the analysis of Crinkled in caspase-mediated cell differentiation and cell migration. Also, we generated fluorescently labelled transgenic flies for tis analysis</gtr:description><gtr:id>0D467B0B-9144-4FD9-A697-41232C62BC8C</gtr:id><gtr:impact>This research material allows the analysis of Myo7A during normal physiology and disease settings</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Crinkled transgenic flies</gtr:title><gtr:type>Model of mechanisms or symptoms - non-mammalian in vivo</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>we have generated various cell lines that harbour specific mutations in the cIAP gene</gtr:description><gtr:id>46A91029-D4E4-4ADA-8184-4BEF0CCF3E18</gtr:id><gtr:impact>This allows the dissection of inflammation and cell death, and provide important insights for future anti-cancer therapies.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>IAP research reagents</gtr:title><gtr:type>Cell line</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>we developed improved techniques to apply the CRISPR/CAS9 technique to delete specific genes from the genome</gtr:description><gtr:id>C2FEC73F-BD42-4CD8-85D8-1A4C1533BA95</gtr:id><gtr:impact>This will improve the way through which we analyse the function of specific genes.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>CRISPR mediated deletion of specific DNA regions</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We developed a new method that allows the characterisation of specific Ubiquitin linkage types on specific lysine residues. This is important because specific Ubiquitin linkages emanate specific signalling events. However, so far it has been impossible to characterise this. This is the first time that it will be possible to map the linkage types on specific lysine residues.</gtr:description><gtr:id>8AB823EF-B2CF-44DC-95C0-6EC9C07C8872</gtr:id><gtr:impact>This represents a paradigm shift in the way Ub signalling will be analysed. This method will help to characterise specific signalling events in vivo.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Prescission mediated characterisation of Ubiquitin linkages on specific lysine residues</gtr:title><gtr:type>Technology assay or reagent</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Stable cell lines expressing dominant-negative forms of MYOSIN-7A were generated.</gtr:description><gtr:id>8D506D3B-D79E-4FA6-9A8E-0BE96A6A29F7</gtr:id><gtr:impact>This cell line is useful to characterise the role of MYOSIN-7A in the regulation of cell migration, cell death and cell invasion</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>MYOSIN-7A research reagent</gtr:title><gtr:type>Cell line</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>We have generated various cell lines that lack individual components of the TNF receptor signalling complex</gtr:description><gtr:id>28BE77FA-1A9D-4BC7-9A61-EE7BA78F1910</gtr:id><gtr:impact>The generation of specific knockout cell lines will help the dissection of inflammation and cell death in cancer.</gtr:impact><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>CRISPR knockout cells</gtr:title><gtr:type>Biological samples</gtr:type><gtr:yearFirstProvided>2015</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C2DEB533-03C5-463D-8510-723AE56B6AC1"><gtr:id>C2DEB533-03C5-463D-8510-723AE56B6AC1</gtr:id><gtr:title>Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).</gtr:title><gtr:parentPublicationTitle>Autophagy</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3338e204a3c58e1fab88cb3342a71645"><gtr:id>3338e204a3c58e1fab88cb3342a71645</gtr:id><gtr:otherNames>Klionsky DJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1554-8627</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/4A6E3441-73D6-4373-B4B7-B0DBF84F103C"><gtr:id>4A6E3441-73D6-4373-B4B7-B0DBF84F103C</gtr:id><gtr:title>PIM1 kinase regulates cell death, tumor growth and chemotherapy response in triple-negative breast cancer.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/3466d4cb306386a6ec24e3885a13e439"><gtr:id>3466d4cb306386a6ec24e3885a13e439</gtr:id><gtr:otherNames>Bras?-Maristany F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A8504946-20E3-4806-956C-59251A69DE3F"><gtr:id>A8504946-20E3-4806-956C-59251A69DE3F</gtr:id><gtr:title>Ubiquitin-mediated regulation of RhoGTPase signalling: IAPs and HACE1 enter the fray.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/65a312eda4e497bd2e1fa36faf866332"><gtr:id>65a312eda4e497bd2e1fa36faf866332</gtr:id><gtr:otherNames>Orme M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/13B9E239-6FC5-4434-8626-204DE39C9237"><gtr:id>13B9E239-6FC5-4434-8626-204DE39C9237</gtr:id><gtr:title>Inhibitor of apoptosis proteins in Drosophila: gatekeepers of death.</gtr:title><gtr:parentPublicationTitle>Apoptosis : an international journal on programmed cell death</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/65a312eda4e497bd2e1fa36faf866332"><gtr:id>65a312eda4e497bd2e1fa36faf866332</gtr:id><gtr:otherNames>Orme M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1360-8185</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/653F9F80-3C7A-4B52-AF3F-1DB386ED2B20"><gtr:id>653F9F80-3C7A-4B52-AF3F-1DB386ED2B20</gtr:id><gtr:title>RET Functions as a Dual-Specificity Kinase that Requires Allosteric Inputs from Juxtamembrane Elements.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/7948cf69d3fd9bbc3193aa1a94a63005"><gtr:id>7948cf69d3fd9bbc3193aa1a94a63005</gtr:id><gtr:otherNames>Plaza-Menacho I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/06EB4504-623A-488E-A917-D6A75BC10799"><gtr:id>06EB4504-623A-488E-A917-D6A75BC10799</gtr:id><gtr:title>Ubiquitin-Mediated Regulation of Cell Death, Inflammation, and Defense of Homeostasis.</gtr:title><gtr:parentPublicationTitle>Current topics in developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/07a24b425e2596582688839f025c42d7"><gtr:id>07a24b425e2596582688839f025c42d7</gtr:id><gtr:otherNames>Meier P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0070-2153</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/39AC78E6-F93F-439A-B3DD-E9AB43D33897"><gtr:id>39AC78E6-F93F-439A-B3DD-E9AB43D33897</gtr:id><gtr:title>Signal Integration by the I?B Protein Pickle Shapes Drosophila Innate Host Defense.</gtr:title><gtr:parentPublicationTitle>Cell host &amp; microbe</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f71edcfeee53d653c31e6380a6523c25"><gtr:id>f71edcfeee53d653c31e6380a6523c25</gtr:id><gtr:otherNames>Morris O</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1931-3128</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/B748E768-54A5-436B-BAA6-3F6F6AD5F66E"><gtr:id>B748E768-54A5-436B-BAA6-3F6F6AD5F66E</gtr:id><gtr:title>The unconventional myosin CRINKLED and its mammalian orthologue MYO7A regulate caspases in their signalling roles.</gtr:title><gtr:parentPublicationTitle>Nature communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1e10a72909aad50e20bd2954e89375ef"><gtr:id>1e10a72909aad50e20bd2954e89375ef</gtr:id><gtr:otherNames>Orme MH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2041-1723</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/BAD557D3-781D-43C9-817B-0D0298C3B69D"><gtr:id>BAD557D3-781D-43C9-817B-0D0298C3B69D</gtr:id><gtr:title>Inhibitor of apoptosis (IAP) proteins-modulators of cell death and inflammation.</gtr:title><gtr:parentPublicationTitle>Cold Spring Harbor perspectives in biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ae8c6dc16d2065a979d0abeb65ac95e0"><gtr:id>ae8c6dc16d2065a979d0abeb65ac95e0</gtr:id><gtr:otherNames>Silke J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1943-0264</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/A8B69B2D-C4C5-4193-9EC3-66390374EA8F"><gtr:id>A8B69B2D-C4C5-4193-9EC3-66390374EA8F</gtr:id><gtr:title>The regulatory isoform rPGRP-LC induces immune resolution via endosomal degradation of receptors.</gtr:title><gtr:parentPublicationTitle>Nature immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/f02324f18f4561f82c79d8b35bdda2ea"><gtr:id>f02324f18f4561f82c79d8b35bdda2ea</gtr:id><gtr:otherNames>Neyen C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1529-2908</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/D060E922-C593-4EE8-9053-07F5537E3C9D"><gtr:id>D060E922-C593-4EE8-9053-07F5537E3C9D</gtr:id><gtr:title>An inhibitory mono-ubiquitylation of the Drosophila initiator caspase Dronc functions in both apoptotic and non-apoptotic pathways.</gtr:title><gtr:parentPublicationTitle>PLoS genetics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/93aeb91dd413b4eab1506212e096e755"><gtr:id>93aeb91dd413b4eab1506212e096e755</gtr:id><gtr:otherNames>Kamber Kaya HE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1553-7390</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G1000089</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>